STOCK TITAN
  1. Home
  2. SEC Filings
  3. AYI
  4. [Form 4] ACUITY INC. (DE) Insider Trading Activity

Acuity CEO Neil Ashe sells 13,217 shares under plan

For the November 2 transactions, reported weighted-average sale prices were $323.45 and $325.00 per share.

Available on EDGAR Accepted by SEC EDGAR
Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Acuity Inc. (AYI) President & CEO Neil Ashe sold 13,217 shares of common stock in 13 reported transactions on October 30 and November 2, 2026. The transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted July 1, 2026.

Insider ASHE NEIL
Role President & CEO
Sold 13,217 shs ($4.23M)
Type Security Shares Price Value
Sale Common Stock F1 3,000 $323.45 $970K
Sale Common Stock F1 1,000 $325.00 $325K
Sale Common Stock F1, F2 760 $313.98 $239K
Sale Common Stock F1, F3 1,040 $315.02 $328K
Sale Common Stock F1, F4 817 $316.02 $258K
Sale Common Stock F1, F5 560 $317.32 $178K
Sale Common Stock F1, F6 2,640 $318.54 $841K
Sale Common Stock F1, F7 800 $319.22 $255K
Sale Common Stock F1, F8 772 $320.48 $247K
Sale Common Stock F1, F9 388 $321.80 $125K
Sale Common Stock F1, F10 920 $323.04 $297K
Sale Common Stock F1, F11 238 $323.86 $77K
Sale Common Stock F1, F12 282 $325.07 $92K
Holdings After Transaction: Common Stock — 64,858 shares (Direct)
Footnotes (12)
  1. F1. The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.55 to $314.45, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.55 to $315.49, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.69 to $316.39, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.79 to $317.71, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  6. F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.90 to $318.87, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  7. F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.90 to $319.71, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  8. F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.11 to $320.98, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  9. F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.28 to $322.26, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  10. F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.51 to $323.49, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  11. F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.68 to $324.51 inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  12. F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.72 to $325.19, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Shares sold 13,217 shares Across 13 reported transactions on October 30 and November 2, 2026
Weighted-average sale price $323.45 per share 3,000 shares sold on November 2, 2026
Weighted-average sale price $325.00 per share 1,000 shares sold on November 2, 2026
Weighted-average sale price $313.98 per share 760 shares sold on October 30, 2026
Weighted-average sale price $325.07 per share 282 shares sold on October 30, 2026
Rule 10b5-1 trading plan regulatory
"occurred automatically pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Reporting Person regulatory
"adopted by the Reporting Person on July 1, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AYI shares did Neil Ashe sell?
Neil Ashe, Acuity Inc.'s President & CEO, reported sales of 13,217 shares on October 30 and November 2, 2026. The transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted July 1, 2026.

What prices were reported for Neil Ashe's November 2 AYI sales?
The reported weighted-average sale prices were $323.45 per share for 3,000 shares and $325.00 per share for 1,000 shares on November 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ASHE NEIL
(Last)(First)(Middle)
C/O ACUITY INC.
1170 PEACHTREE STREET, NE, SUITE 1200
(Street)
ATLANTA GEORGIA 30309
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ACUITY INC. (DE) [ AYI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/30/2026S(1)760D$313.98(2)77,315D
Common Stock10/30/2026S(1)1,040D$315.02(3)76,275D
Common Stock10/30/2026S(1)817D$316.02(4)75,458D
Common Stock10/30/2026S(1)560D$317.32(5)74,898D
Common Stock10/30/2026S(1)2,640D$318.54(6)72,258D
Common Stock10/30/2026S(1)800D$319.22(7)71,458D
Common Stock10/30/2026S(1)772D$320.48(8)70,686D
Common Stock10/30/2026S(1)388D$321.8(9)70,298D
Common Stock10/30/2026S(1)920D$323.04(10)69,378D
Common Stock10/30/2026S(1)238D$323.86(11)69,140D
Common Stock10/30/2026S(1)282D$325.07(12)68,858D
Common Stock11/02/2026S(1)3,000D$323.4565,858D
Common Stock11/02/2026S(1)1,000D$32564,858D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.55 to $314.45, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.55 to $315.49, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.69 to $316.39, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.79 to $317.71, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.90 to $318.87, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.90 to $319.71, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.11 to $320.98, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.28 to $322.26, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.51 to $323.49, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.68 to $324.51 inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.72 to $325.19, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Remarks:
/s/ Chanda Kirchner, Attorney-in-Fact for Neil Ashe11/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on AYI

All AYI news

Trending in the feed

MRNA
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates Open the live feed